Angiotensin-(1–7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Release of norepinephrine (NE) by the hypothalamic nuclei may contribute to regulation of sympathetic nervous system (SNS) activity. Angiotensin-(1–7) [Ang-(1–7)] has an antihypertensive effect and may decrease SNS activity. We tested the hypothesis that Ang-(1–7) inhibits the release of NE in hypothalami, via the Ang-(1–7) and angiotensin II type 2 (AT 2 ) receptors, acting through a bradykinin (BK)/NO-dependent mechanism. Hypothalami from normotensive controls and spontaneously hypertensive rats (SHR) were isolated and endogenous NE stores labeled by incubating the tissues with [ 3 H]NE. [ 3 H]NE release from the hypothalami was stimulated by KCl in the presence or absence of Ang-(1–7) alone or combined with various antagonists and inhibitors. Ang-(1–7) significantly attenuated K + -induced NE release by hypothalami from normotensive rats but was more potent in SHR. The Ang-(1–7) receptor antagonist [ d -Ala 7 ]Ang-(1–7), the AT 2 receptor antagonist PD 123319, and the BK B 2 receptor antagonist icatibant all blocked the inhibitory effect of Ang-(1–7) on K + -stimulated NE release in SHR. The inhibitory effect of Ang-(1–7) disappeared in the presence of the NO synthase inhibitor N G -nitro- l -arginine methyl ester and was restored by the precursor of NO, l -arginine. The diminished NE release caused by Ang-(1–7) was blocked by a soluble guanylyl cyclase inhibitor as well as by a cGMP-dependent protein kinase (PKG). We concluded that Ang-(1–7) decreases NE release from the hypothalamus via the Ang-(1–7) or AT 2 receptors, acting through a BK/NO-mediated mechanism that stimulates cGMP/PKG signaling. In this way, Ang-(1–7) may decrease SNS activity and exert an antihypertensive effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic Activation in the Pathogenesis of Hypertension and Progression of Organ Damage
Mancia, G., Grassi, G., Giannattasio, C., & Seravalle, G. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.724 · Cited by 471
Cited by
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Angiotensin‐converting enzyme 2 in the brain: properties and future directions
Xia, H., & Lazartigues, E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05723.x · Cited by 321
ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
Xu, P., Sriramula, S., & Lazartigues, E. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00222.2010 · Cited by 283
Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241
Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
Abate, G., Memo, M., & Uberti, D. (2020) · Healthcare · doi:10.3390/healthcare8030286 · Cited by 56
Metadata
- Authors
- Gironacci, M. M., Valera, M. S., Yujnovsky, I., & Peña, C.
- Venue
- Hypertension
- Published
- 2004-11
- Volume
- 44
- Issue
- 5
- Pages
- 783-787
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2166190242
- Cited by
- 95
- References
- 1
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin-(1–7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats. https://app.cochat.ai/papers/10.1161/01.hyp.0000143850.73831.9d
- The paper
- Gironacci, M. M., Valera, M. S., Yujnovsky, I., & Peña, C. (2004). Angiotensin-(1–7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats. Hypertension. https://doi.org/10.1161/01.hyp.0000143850.73831.9d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.